Redmile Group LLC 13D and 13G filings for LAVA Therapeutics N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:26 pm Sale | 2023-12-31 | 13G | LAVA Therapeutics N.V. LVTX | Redmile Group LLC | 2,074,372 7.900% | -741,824 (-26.34%) | Filing |
| 2022-02-14 5:07 pm Sale | 2021-12-31 | 13G | LAVA Therapeutics N.V. LVTX | Redmile Group LLC | 2,816,196 10.900% | -8,213 (-0.29%) | Filing |
| 2021-04-08 4:11 pm Purchase | 2021-03-29 | 13G | LAVA Therapeutics N.V. LVTX | Redmile Group LLC | 2,824,409 11.100% | 2,824,409 (New Position) | Filing |